Shock and Multiple-Organ Dysfunction after Self-Administration of Salmonella Endotoxin
Open Access
- 20 May 1993
- journal article
- case report
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 328 (20) , 1457-1460
- https://doi.org/10.1056/nejm199305203282005
Abstract
Endotoxin, a lipopolysaccharide component of the outer membrane of gram-negative bacteria, is involved in the pathogenesis of septic shock, but it is unclear whether endotoxin alone is capable of causing all the manifestations of the septic shock syndrome. In animals, endotoxin causes many of the clinical features1 but produces a low-cardiac-output form of shock that is unlike the hyperdynamic cardiovascular profile of septic shock in humans2,3. In humans, the administration of endotoxin (4 ng per kilogram of body weight) triggers the release of cytokines,4 activates the coagulation and fibrinolytic systems,5,6 and causes a decrease in systemic vascular resistance and an increase in cardiac output7. At these low doses, however, endotoxin does not cause shock, disseminated intravascular coagulation, or clinically important organ dysfunction. A septic shock-like syndrome occurred in patients treated for cancer with crude preparations of endotoxin8 and in patients who received transfusions of blood products contaminated with gram-negative bacteria9. These reports, however, did not include detailed hemodynamic data, and other bacterial products may have contributed to the clinical signs and symptoms. We describe a patient who self-administered a single large dose of endotoxin and in whom the full clinical manifestations of septic shock syndrome developed.Keywords
This publication has 20 references indexed in Scilit:
- Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents.The Journal of Experimental Medicine, 1991
- The Cardiovascular Response of Normal Humans to the Administration of EndotoxinNew England Journal of Medicine, 1989
- Promotion and Subsequent Inhibition of Plasminogen Activation after Administration of Intravenous Endotoxin to Normal SubjectsNew England Journal of Medicine, 1989
- Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock.Journal of Clinical Investigation, 1989
- The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.The Journal of Experimental Medicine, 1989
- Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious PurpuraNew England Journal of Medicine, 1988
- Serial cardiovascular variables in survivors and nonsurvivors of human septic shockCritical Care Medicine, 1987
- Spectrum of cardiovascular function during gram-negative sepsisProgress in Cardiovascular Diseases, 1981
- The role of endotoxin during typhoid fever and tularemia in manJournal of Clinical Investigation, 1969
- DISTRIBUTION AND CLEARANCE OF CIRCULATING ENDOTOXIN*Journal of Clinical Investigation, 1963